REMOTE Ischemic Perconditioning Among Acute Ischemic Stroke Patients in Catalonia

Rationale: Remote ischemic perconditioning during cerebral ischemia (RIPerC) refers to the application of brief episodes of transient limb ischemia commonly to a limb, it represents a new safe, simple and low-cost paradigm in neuroprotection. Aim and/or Hypothesis: To evaluate the effects of RIPerC...

Descripción completa

Detalles Bibliográficos
Autores: Purroy, Francisco|||0000-0002-1808-5968, Arque, Gloria|||0000-0002-8039-3726, Mauri, Gerard, García-Vázquez, Cristina, Vicente-Pascual, Mikel, Pereira, Cristina, Vázquez Justes, Daniel|||0000-0002-7946-2982, Torres-Querol, Coral|||0000-0002-2513-7076, Vena, Ana, Abilleira i Castells, Sònia|||0000-0002-5587-128X, Cardona, Pere-Joan|||0000-0001-5623-7873, Forne, Carles|||0000-0002-8133-3274, Jiménez-Fàbrega, Xavier, Pagola, Jorge|||0000-0002-0725-1369, Portero-Otin, Manuel, Rodriguez Campello, Ana Maria|||0000-0001-8621-1420, Rovira, Alex|||0000-0002-2132-6750, Martí-Fàbregas, Joan|||0000-0001-9229-8649
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:253019
Acceso en línea:https://ddd.uab.cat/record/253019
https://dx.doi.org/urn:doi:10.3389/fneur.2020.569696
Access Level:acceso abierto
Palabra clave:Ischemic stroke
Remote ischemic perconditioning (rPerC)
Neuroprotection
Infarct size (IS)
Metabolomics (OMICS)
Descripción
Sumario:Rationale: Remote ischemic perconditioning during cerebral ischemia (RIPerC) refers to the application of brief episodes of transient limb ischemia commonly to a limb, it represents a new safe, simple and low-cost paradigm in neuroprotection. Aim and/or Hypothesis: To evaluate the effects of RIPerC on acute ischemic stroke (AIS) patients, applied in the ambulance, to improve functional outcomes compared with standard of care. Sample Size Estimates: A sample size of 286 patients in each arm achieves 80% power to detect treatment differences of 14% in the outcome, using a two-sided binomial test at significance level of 0.05, assuming that 40% of the control patients will experience good outcome and an initial misdiagnosis rate of 29%. Methods and Design: We aim to conduct a multicentre study of pre-hospital RIPerC application in AIS patients. A total of 572 adult patients diagnosed of suspected clinical stroke within 8 h of symptom onset and clinical deficit.